MTHFR 677 C>T Polymorphism Reveals Functional Importance for 5-Methyltetrahydrofolate, Not Homocysteine, in Regulation of Vascular Redox State and Endothelial Function in Human Atherosclerosis
Author(s) -
Charalambos Antoniades,
Cheerag Shirodaria,
Paul Leeson,
O Baarholm,
Tim Van-Assche,
Colin Cunnington,
Ravi Pillai,
C Ratnatunga,
Dimitris Tousoulis,
Christodoulos Stefanadis,
Helga Refsum,
Keith M. Chan
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.108.808675
Subject(s) - homocysteine , methylenetetrahydrofolate reductase , nitric oxide , medicine , nitric oxide synthase , endocrinology , vascular disease , endothelium , endothelial dysfunction , hyperhomocysteinemia , superoxide , biology , pharmacology , biochemistry , enzyme , genotype , gene
The role of circulating homocysteine as an atherosclerosis risk factor has recently been questioned. However, 5-methyl-tetrahydrofolate (5-MTHF), the circulating metabolite of folic acid participating in homocysteine metabolism, has direct effects on vascular function. We sought to distinguish the effects of plasma versus vascular tissue 5-MTHF and homocysteine on vascular redox and endothelial nitric oxide bioavailability in human vessels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom